Gel4Med Receives Prestigious NIH Award to Advance Wound Care and Surgical Reconstruction Portfolio

Funding Rounds

▤ Summary

Gel4Med received a competitive NIH SBIR Phase II award to support the development of its wound care and surgical reconstruction portfolio. The company will use the three-year funding period to advance peptide-based membranes for biofilm prevention and chronic wound management. It will also expand its commercially available products and develop offerings for outpatient and physician office settings. The announcement highlights Gel4Med’s Smart Materials Platform and its synthetic biomaterials approach to regenerative medicine.

$ Funding

$
Amount None Total raised
□
Date July 14, 2025 Announcement date
◎
Investors National Science Foundation, Breakout Labs, Massachusetts Life Sciences Center, MassVentures Lead investors
▥
Company gelformed.com Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies